217 related articles for article (PubMed ID: 38485837)
1. Genomic testing for germline predisposition to hematologic malignancies.
Hwang SM
Blood Res; 2024 Mar; 59(1):12. PubMed ID: 38485837
[TBL] [Abstract][Full Text] [Related]
2. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic work-up of hematological malignancies with underlying germline predisposition disorders (GPD).
Kanagal-Shamanna R; Schafernak KT; Calvo KR
Semin Diagn Pathol; 2023 Nov; 40(6):443-456. PubMed ID: 37977953
[TBL] [Abstract][Full Text] [Related]
4. Lessons From Pediatric MDS: Approaches to Germline Predisposition to Hematologic Malignancies.
Avagyan S; Shimamura A
Front Oncol; 2022; 12():813149. PubMed ID: 35356204
[TBL] [Abstract][Full Text] [Related]
5. Germline Genetic Predisposition to Hematologic Malignancy.
Furutani E; Shimamura A
J Clin Oncol; 2017 Mar; 35(9):1018-1028. PubMed ID: 28297620
[TBL] [Abstract][Full Text] [Related]
6. Review of guidelines for the identification and clinical care of patients with genetic predisposition for hematological malignancies.
Schlegelberger B; Mecucci C; Wlodarski M
Fam Cancer; 2021 Oct; 20(4):295-303. PubMed ID: 34057692
[TBL] [Abstract][Full Text] [Related]
7. Genetic predisposition to leukemia and other hematologic malignancies.
Feurstein S; Drazer MW; Godley LA
Semin Oncol; 2016 Oct; 43(5):598-608. PubMed ID: 27899193
[TBL] [Abstract][Full Text] [Related]
8. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
9. Myeloid neoplasms with germline predisposition: Practical considerations and complications in the search for new susceptibility loci.
Carraway HE; LaFramboise T
Best Pract Res Clin Haematol; 2020 Sep; 33(3):101191. PubMed ID: 33038980
[TBL] [Abstract][Full Text] [Related]
10. Clinical utility of targeted next-generation sequencing for the diagnosis of myeloid neoplasms with germline predisposition.
Andrés-Zayas C; Suárez-González J; Rodríguez-Macías G; Dorado N; Osorio S; Font P; Carbonell D; Chicano M; Muñiz P; Bastos M; Kwon M; Díez-Martín JL; Buño I; Martínez-Laperche C
Mol Oncol; 2021 Sep; 15(9):2273-2284. PubMed ID: 33533142
[TBL] [Abstract][Full Text] [Related]
11. The Emerging Role of Hematopathologists and Molecular Pathologists in Detection, Monitoring, and Management of Myeloid Neoplasms with Germline Predisposition.
Kanagal-Shamanna R
Curr Hematol Malig Rep; 2021 Aug; 16(4):336-344. PubMed ID: 34028637
[TBL] [Abstract][Full Text] [Related]
12. Germline predisposition to hematopoietic malignancies.
Feurstein S; Drazer M; Godley LA
Hum Mol Genet; 2021 Oct; 30(20):R225-R235. PubMed ID: 34100074
[TBL] [Abstract][Full Text] [Related]
13. Hereditary cancer syndrome-associated pathogenic variants are common in patients with hematologic malignancies subsequent to primary solid cancer.
Oh J; Kim YR; Kim Y; Kim B; Park KS; Nam SH; Lee KA
J Cancer; 2021; 12(14):4288-4294. PubMed ID: 34093829
[No Abstract] [Full Text] [Related]
14. The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Gurbuxani S; Hochman MJ; DeZern AE; Shimamura A
Am Soc Clin Oncol Educ Book; 2023 Jun; 43():e390026. PubMed ID: 37307513
[TBL] [Abstract][Full Text] [Related]
15. Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.
Desai AV; Perpich M; Godley LA
Front Pediatr; 2017; 5():252. PubMed ID: 29270394
[TBL] [Abstract][Full Text] [Related]
16. Insights into the Molecular Mechanisms of Genetic Predisposition to Hematopoietic Malignancies: The Importance of Gene-Environment Interactions.
Cobaleda C; Godley LA; Nichols KE; Wlodarski MW; Sanchez-Garcia I
Cancer Discov; 2024 Mar; 14(3):396-405. PubMed ID: 38426560
[TBL] [Abstract][Full Text] [Related]
17. Next-Generation Sequencing of
Bannon SA; Routbort MJ; Montalban-Bravo G; Mehta RS; Jelloul FZ; Takahashi K; Daver N; Oran B; Pemmaraju N; Borthakur G; Naqvi K; Issa G; Sasaki K; Alvarado Y; Kadia TM; Konopleva M; Shamanna RK; Khoury JD; Ravandi F; Champlin R; Kantarjian HM; Bhalla K; Garcia-Manero G; Patel KP; DiNardo CD
Front Oncol; 2020; 10():582213. PubMed ID: 33585199
[TBL] [Abstract][Full Text] [Related]
18. Practical considerations for diagnosis and management of patients and carriers.
Niemeyer CM; Mecucci C
Semin Hematol; 2017 Apr; 54(2):69-74. PubMed ID: 28637619
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Children and Young Adults with Hematologic Malignancies and Blood Disorders: The Columbia University Experience.
Marks LJ; Oberg JA; Pendrick D; Sireci AN; Glasser C; Coval C; Zylber RJ; Chung WK; Pang J; Turk AT; Hsiao SJ; Mansukhani MM; Glade Bender JL; Kung AL; Sulis ML
Front Pediatr; 2017; 5():265. PubMed ID: 29312904
[TBL] [Abstract][Full Text] [Related]
20. Inherited predisposition to haematopoietic malignancies: overcoming barriers and exploring opportunities.
Trottier AM; Godley LA
Br J Haematol; 2021 Aug; 194(4):663-676. PubMed ID: 33615436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
